In Vivo Photoacoustic Imaging of Livers Using Biodegradable Hyaluronic Acid‐Conjugated Silica Nanoparticles

Abstract

The diagnosis of liver diseases is generally carried out via ultrasound imaging, computed tomography, and magnetic resonance imaging. The emerging photoacoustic imaging is an attractive alternative to diagnose even early stage of liver diseases providing high‐resolution anatomical and functional information in deep tissue noninvasively. However, the liver has insufficient photoacoustic contrast due to low optical absorbance in the near‐infrared windows. Here, a new hyaluronate–silica nanoparticle (HA–SiNP) conjugate for liver‐specific delivery and imaging for the diagnosis of liver diseases is developed. The HA–SiNP conjugates show high liver‐specific targeting efficiency, strong optical absorbance near‐infrared windows, excellent biocompatibility, and biodegradability. The liver‐specific targeting efficiency is verified by in vitro cellular uptake test, and in vivo and ex vivo photoacoustic imaging. In vivo photoacoustic imaging shows that photoacoustic amplitude in the liver injected with HA–SiNP conjugates is 4.4 times higher than that of the liver injected with SiNP. The biocompatibility and biodegradability of HA–SiNP conjugates are verified by cell viability test, optical spectrum analysis of urine, and inductively coupled plasma‐mass spectroscopy (ICP‐MS) analysis. Taken together, HA–SiNP conjugates may be developed as a promising liver targeted photoacoustic imaging contrast agent and liver‐targeted drug delivery agent.

Highly-Soluble Cyanine J-aggregates Entrapped by Liposomes for In Vivo Optical Imaging around 930 nm

“…As shown by the highlighted white and yellow squares, DPC-Cy photoacoustic signal was localized in the spleen, but not the liver. Interestingly, Kim et al recently reported techniques for enhancing localization of photoacoustic probes specifically to the liver49, which suggests the future possibility for combining multiplexed, organ-specific, color-coded contrast agents.…”

Encapsulation and Release of Essential Oils in Functional Silica Nanocontainers

“…Hyaluronic acid (HA) is a ubiquitous extracellular matrix component synthesized by fibroblasts. HA was conjugated to the silica nanoparticles and was found to enhance cell viability of normal cells compared to nonmodified nanoparticles even at high concentration. − HA has been reported as a specific targeting ligand for the specific cell surface receptor Cluster determinant 44 (CD44), which is overexpressed in liver, ovarian, , breast, − and colon tumor cancers . Consequently, nanocarriers modified with HA displayed superior cellular uptake, cancer cell death, and viability for the human normal cell.…”

Application of photoacoustic computed tomography in biomedical imaging: A literature review

“…Exogenous agents can be prepared as required, with an increase of two to three orders of magnitude in molar absorption coefficients in specific wavelengths compared to endogenous contrast agents, which is of benefit to both dynamic imaging and kinetic imaging 103 . For example, IR‐780 can be used to construct super‐high‐resolution cerebral vascular network structures for hemodynamic studies 103 ; 2‐NBDG can be used for quantitative imaging of brain metabolism 10 ; hyaluronate–silica nanoparticle can be used as biocompatible liver‐targeted PA contrast agents 153 ; indocyanine green can mark lung tumor cells 154 ; and gold nanoparticles can be used in the assistant diagnosis of early kidney damage and contrast imaging of cancer cells 155 . With stronger interdisciplinary collaborations between PACT and materials science researchers, more and more exogenous contrast agents for PACT will be developed in the future for target‐specific functional and molecular imaging.…”